NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits ... from Zantac (ranitidine), most of which had been consolidated in a Delaware action. Law firms ...

To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...

Why: Rosen Law Firm, a global investor rights ... study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors suffered ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between ...

U.S. Sen. Richard Blumenthal (D-CT) called on U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D. to ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action lawsuit in the U.S. District Court for the Eastern ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10 (b) and 20 ...

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder ... estimate the liability" it would face from lawsuits related to Zantac. Based on these facts, the Company’s public ...